Wire Stories
BeiGene Announces Brazil Approvals for BRUKINSA� As a Treatment for Rare Blood Cancers
BRUKINSA now approved in Brazil for three indications CAMBRIDGE, Mass., & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–BeiGene, (NASDAQ: BGNE; HKEX: 06160; SSE: 688235),...